MORGAN CRITES: Open Payments
NPI 1780349167 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 7 payments from 6 companies in 2025. Trend: 2023 $355 · 2024 $313 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $131 |
| JAZZ PHARMACEUTICALS INC. | 1 | $118 |
| E.R. Squibb & Sons, L.L.C. | 1 | $113 |
| Pharmacosmos Therapeutics Inc. | 1 | $43 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Tempus AI, Inc | 1 | $27 |
Products named: IMDELLTRA (AMG757), ZEPZELCA, OPDIVO, MONOFERRIC, XT CDX, KEYTRUDA, KEYTRUDA QLEX.
Industry payments across IN — which companies pay providers there.
